DK0941998T3 - 3,6-ketalmakrolidantibiotika - Google Patents

3,6-ketalmakrolidantibiotika

Info

Publication number
DK0941998T3
DK0941998T3 DK99301325T DK99301325T DK0941998T3 DK 0941998 T3 DK0941998 T3 DK 0941998T3 DK 99301325 T DK99301325 T DK 99301325T DK 99301325 T DK99301325 T DK 99301325T DK 0941998 T3 DK0941998 T3 DK 0941998T3
Authority
DK
Denmark
Prior art keywords
ketal
macrolide antibiotics
macrolide
antibiotics
ketal macrolide
Prior art date
Application number
DK99301325T
Other languages
Danish (da)
English (en)
Inventor
Kristin M Lundy
Hengmiao Cheng
Subas M Sakya
Peter Bertinato
Martha L Minich
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK0941998T3 publication Critical patent/DK0941998T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK99301325T 1998-03-03 1999-02-23 3,6-ketalmakrolidantibiotika DK0941998T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7663098P 1998-03-03 1998-03-03

Publications (1)

Publication Number Publication Date
DK0941998T3 true DK0941998T3 (da) 2004-09-20

Family

ID=22133253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99301325T DK0941998T3 (da) 1998-03-03 1999-02-23 3,6-ketalmakrolidantibiotika

Country Status (17)

Country Link
US (1) US6043226A (ja)
EP (1) EP0941998B1 (ja)
JP (1) JP3666788B2 (ja)
CN (1) CN1244532A (ja)
AR (1) AR016715A1 (ja)
AT (1) ATE275151T1 (ja)
AU (1) AU741435B2 (ja)
BR (1) BR9900856A (ja)
CA (1) CA2263203C (ja)
DE (1) DE69919769T2 (ja)
DK (1) DK0941998T3 (ja)
ES (1) ES2226282T3 (ja)
HU (1) HUP9900492A3 (ja)
NO (1) NO312366B1 (ja)
NZ (1) NZ334442A (ja)
PT (1) PT941998E (ja)
ZA (1) ZA991664B (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
ID28286A (id) 1998-11-03 2001-05-10 Pfizer Prod Inc Antibiotik-antibiotik makrolida baru
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
CN1241931C (zh) 1999-04-16 2006-02-15 高山生物科学股份有限公司 大环内酯抗感染药物
US6514944B2 (en) * 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) * 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
IL145739A0 (en) * 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
EP1343879B1 (en) * 2000-11-07 2014-01-08 Morphotek, Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
WO2004073492A2 (en) * 2003-02-14 2004-09-02 Massachusetts Eye And Ear Infirmary Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
PL1836211T3 (pl) * 2004-12-21 2010-07-30 Pfizer Prod Inc Makrolidy
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
WO2009039177A1 (en) * 2007-09-17 2009-03-26 Enanta Pharmaceuticals, Inc. 6, 11-bicycloides: bridged biaryl macrolide derivatives
WO2018193126A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as antibacterial agents
CA3060892A1 (en) 2017-04-20 2018-10-25 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193111A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
US11560395B2 (en) 2017-04-20 2023-01-24 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193116A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018195446A1 (en) 2017-04-21 2018-10-25 Lisanti Michael P Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
EP3612187B1 (en) 2017-04-21 2022-04-13 Lunella Biotech, Inc. Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
WO2018213764A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
CR20190524A (es) 2017-05-19 2020-01-10 Lunella Biotech Inc Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas
MX2019014806A (es) 2017-06-26 2020-02-10 Lunella Biotech Inc Mitocetoscinas: agentes terapeuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en celulas cancerosas.
GB201817083D0 (en) * 2018-10-19 2018-12-05 Novintum Biotechnology Gmbh Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
EP0344106A3 (de) * 1988-05-24 1990-01-31 Ciba-Geigy Ag Blaue Dispersionsfarbstoffe und Mischungen blauer Dispersionsfarbstoffe
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5602239A (en) * 1993-01-26 1997-02-11 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
JP2000509712A (ja) * 1996-05-07 2000-08-02 アボツト・ラボラトリーズ ６―ｏ―置換エリスロマイシン及びその製造方法

Also Published As

Publication number Publication date
CA2263203A1 (en) 1999-09-03
EP0941998A3 (en) 1999-10-06
AU1856299A (en) 1999-09-16
AR016715A1 (es) 2001-07-25
NZ334442A (en) 2000-03-27
CA2263203C (en) 2002-09-03
AU741435B2 (en) 2001-11-29
NO991012D0 (no) 1999-03-02
BR9900856A (pt) 2000-04-25
CN1244532A (zh) 2000-02-16
ES2226282T3 (es) 2005-03-16
ATE275151T1 (de) 2004-09-15
DE69919769T2 (de) 2005-01-27
PT941998E (pt) 2004-12-31
ZA991664B (en) 2000-10-12
JPH11315093A (ja) 1999-11-16
US6043226A (en) 2000-03-28
EP0941998B1 (en) 2004-09-01
EP0941998A2 (en) 1999-09-15
JP3666788B2 (ja) 2005-06-29
NO312366B1 (no) 2002-04-29
NO991012L (no) 1999-09-06
HU9900492D0 (en) 1999-04-28
HUP9900492A2 (hu) 1999-09-28
HUP9900492A3 (en) 2001-08-28
DE69919769D1 (de) 2004-10-07

Similar Documents

Publication Publication Date Title
DE69919769D1 (de) 3,6-Ketal-Makrolidantibiotika
IS5528A (is) Ný makrólíð
ATE322910T1 (de) Neuartige antibiotika
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DE69838651D1 (de) Erythromycinderivate
IS5919A (is) Ný makrólíð sýklalyf
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
IS5251A (is) 9-oxím erýþrómýsín afleiður
ATE256694T1 (de) Ketolid-antibiotika
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
NO20010250D0 (no) Nocatiacin-antibiotika
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DK1149106T3 (da) 4,5-azolo-oxindoler
ID26368A (id) Turunan-turunan 2 deoksi higromisin
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina